NOTES TO THE GROUP ANNUAL FINANCIAL STATEMENTS l NOTE 11

11. Investment in subsidiaries

  GROUP
R'000
  GROUP
R'000
  COMPANY
R'000
  COMPANY
2013
 

Unlisted investments at cost

    *   *  
* Amounts less than R1,000

Name Main business Country of incorporation Interest held
2014 and 2013      
Directly held      
AfroCentric Resources (Pty) Ltd Dormant South Africa 100.0%
AfroCentric Capital (Pty) Limited Dormant South Africa 100.0%
ACT Healthcare Assets (Pty) Ltd Investment holding South Africa 100.0%
ACT Funding (Pty) Ltd Financing South Africa 100.0%
Indirectly held      
AfroCentric Health Limited Healthcare administration South Africa 94.1%

The indirectly held subsidiary, AfroCentric Health Limited, operates in the healthcare administration industry and all directly held subsidiaries operate in the investment holding and financing industries. The total aggregate assets, liabilities and results of AfroCentric Health Limited Group’s operations are summarised as follows:

Summarised statement of financial position of AHL:

  GROUP
June 2014
R'000
  GROUP
June 2013
R'000
 
Non-current assets (excluding intangible assets) 231 565   261 540  
Intangible assets 453 793   475 912  
Current assets 626 642   538 628  
Total assets 1 312 000   1 276 080  
Non-current liabilities 43 090   52 368  
Current liabilities 198 270   193 536  
Total liabilities 241 360   245 904  
Accumulated non-controlling interest 16 543   17 098  

Summarised statement of comprehensive income of AHL:

  GROUP
June 2014
R'000
  GROUP
June 2013
R'000
 
Revenue 1 954 705   1 771 370  
Profit for the period 192 538   250 847  
Other comprehensive income 83   1 900  
Total comprehensive income 192 621   252 747  
Profit attributable to non-controlling interest 6 283   6 725  
Dividends paid to non-controlling interest 6 838   4 053  

Summarised statement of cash flows of AHL:

  GROUP
June 2014
R'000
  GROUP
June 2013
R'000
 
Net cash inflow from operating activities 126 689   283 063  
Net cash outflow from investing activities (64 811)   (7 107)  
Net cash outflow from financing activities (961)   (112 787)  
Net increase in cash and cash equivalents 61 000   1 990  

NOTES TO THE GROUP ANNUAL FINANCIAL STATEMENTS l NOTE 11